BioCentriq added feeder cell irradiation capabilities to its impressive list of service offerings. In this article, we explain why we thought it was important to add these unique capabilities to our portfolio.  An Overview of …

This summer, BioCentriq ran its first internship program and recruited five talented students to work for ten weeks, allowing them to learn about the biotech industry, conduct research, and make lasting change within the company. …

The BioCentriq team will be attending this year’s Cell & Gene Therapy Manufacturing & Commercialization US Conference during Biotech Week, and two of our team members will be featured panelists. The conference will bring together …

On Friday, September 9, industry leaders and innovators gathered at NJIT for BioNJ’s 2022 Manufacturing Briefing. BioCentriq was proud to serve as a sponsor, and CEO Haro Hartounian, Ph.D., welcomed attendees with opening remarks along …

This July, Rutgers held its Bio Manufacturing Innovation Summit, which brought together advanced bio-manufacturing thought leaders, leading spin-out and growth company innovators, and decision-makers within the industry. The conference was meant to stimulate innovation, impact, …

A Message from CEO and Founder Haro Hartounian, Ph.D. 2022 has already been a year packed with growth and advancement, fueled by the need for regenerative medicine and the individuals working to bring new therapies …

BioCentriq, a subsidiary of the New Jersey Institute of Technology, was acquired by South Korean company GC for $73 million.

Dr. Haro Hartounian, SVP and General Manager of BioCentriq, was recognized as a Sector Star.

Terumo Blood and Cell Technologies (Terumo) and BioCentriq announce the formation of a strategic collaboration.

NJII announces partnership with McKinsey & Company in the launch of a new center to advance operations and manufacturing excellence in cell and gene therapy (CGT).

CaroGen Corporation partners with BioCentriq™ as their partner for clinical manufacturing to support Phase 1 clinical trial. Learn more.

BioCentriq, a cell and gene therapy development and manufacturing center, is pleased to announce that Shannon Eaker of Cytiva has joined its advisory committee. Shannon earned his Ph.D. from the University of Tennessee, Knoxville in …